PATENT CLAIM ANALYSIS

Application Number: 16130898
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "289000"]

Abstract:
Dosage forms, drug delivery systems, methods related to sustained release of dextromethorphan or improved therapeutic effects, and methods of the use of bupropion and dextromethorphan for treating nicotine addiction are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.

Claim (Index 7):
The method of  claim 1 , wherein about 250 mg to about 350 mg of the bupropion is administered to the person daily in two divided doses.

Metadata:
- Claim Count in Document: 74.0
- Percentile: 97.0
- Lexical Diversity: 1.5641
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15164746', '15621882', '15647069', '15645939', '15688660']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.9017962619598212
- 35 USC 102 Novelty (BERT): 0.7062091592408747
- Combined Prediction Score: 0.8822375516879265
- Mean Citation Score: 711.6267
- Max Citation Score: 718.4103
- Similarity Product: 586.129359308946

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test